ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,719Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 387

$659K Total Retail Price of All Prescriptions

Rank: 84 out of 387

360 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 10,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 525 441 1 2
LISINOPRIL 482 385 2 3
FUROSEMIDE 402 323 3 7
GABAPENTIN 352 276 4 10
HYDROCODONE-ACETAMINOPHEN 302 170 S3 5 1
POTASSIUM CHLORIDE 297 286 6 9
OMEPRAZOLE 290 204 7 4
AMLODIPINE BESYLATE 289 269 8 6
SIMVASTATIN 287 253 9 5
METOPROLOL TARTRATE 269 221 10 11
LANTUS 231 196 11 51
FAMOTIDINE 225 181 12 78
WARFARIN SODIUM 224 181 13 17
CITALOPRAM HBR 221 172 14 19
DONEPEZIL HCL 215 196 15 27
TRAZODONE HCL 183 149 16 37
TRAMADOL HCL 176 138 17 14
MIRTAZAPINE 172 119 18 64
CARVEDILOL 172 133 18 21
HYDROCHLOROTHIAZIDE 169 141 20 12
PAROXETINE HCL 167 119 21 52
NAMENDA 165 133 22 35
CYMBALTA 152 112 23 44
RISPERIDONE 149 113 24 70
OLANZAPINE 144 87 25 126
FLUOXETINE HCL 132 86 26 46
METFORMIN HCL 130 108 27 8
GLIPIZIDE 122 122 28 63
NOVOLOG 120 88 29 116
RANITIDINE HCL 110 80 30 45
SERTRALINE HCL 99 31 31 23
KLOR-CON M20 97 65 32 76
ATENOLOL 97 67 32 20
DIVALPROEX SODIUM 96 45 34 113
PHENYTOIN SODIUM EXTENDED 96 47 34 107
QUETIAPINE FUMARATE 96 93 34 88
POLYETHYLENE GLYCOL 3350 92 56 37 57
CLONIDINE HCL 90 82 38 38
IBUPROFEN 90 68 38 85
METOCLOPRAMIDE HCL 89 67 40 125
ATORVASTATIN CALCIUM 88 68 41 13
TAMSULOSIN HCL 86 60 42 32
KLOR-CON M10 84 72 43 149
ALENDRONATE SODIUM 83 78 44 31
FLUTICASONE PROPIONATE 81 61 45 29
ALBUTEROL SULFATE 80 64 46 172
PRAVASTATIN SODIUM 76 52 47 15
PROMETHAZINE HCL 74 33 R 48 82
CARBIDOPA-LEVODOPA 74 60 48 104
BENZTROPINE MESYLATE 72 56 R 50 167
LATANOPROST 72 72 50 258
GLYBURIDE 71 58 R 52 58
MUPIROCIN 69 59 53 188
LOVASTATIN 67 65 54 36
OXYBUTYNIN CHLORIDE ER 67 46 54 120
PHENYTOIN 66 42 56 334
ALLOPURINOL 66 64 56 28
ZOLPIDEM TARTRATE 65 42 58 16
ROPINIROLE HCL 63 50 59 91
MEGESTROL ACETATE 63 54 R 59 123
CIPROFLOXACIN HCL 60 39 61 56
ISOSORBIDE MONONITRATE ER 60 60 61 59
PREDNISONE 59 32 63 43
DIGOXIN 59 42 63 40
IPRATROPIUM-ALBUTEROL 59 45 63 212
TRAVATAN Z 59 49 63 200
HALOPERIDOL 58 46 67 253
LOPERAMIDE 57 45 68 181
FENTANYL 56 30 S2 69 80
DIOVAN 56 56 69 33
LEVETIRACETAM 56 37 69 110
SANTYL 56 47 69 190
CEPHALEXIN 55 46 73 135
METOPROLOL SUCCINATE 54 47 74 18
LYRICA 52 33 75 66
AZITHROMYCIN 52 39 75 49
CLOPIDOGREL 52 31 75 25
HYDRALAZINE HCL 52 48 75 94
ENALAPRIL MALEATE 52 50 75 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.